Lubna Choudhury

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

Lubna Choudhury, Heiko Mahrholdt, Anja Wagner et al. · Journal of the American College of Cardiology · 2002 · 627 citations

Cardiomyopathy, Cardiovascular Disease, Myocardial Scarring +7

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 316 citations · Full text

Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry

Stefan Neubauer, Paul Kolm, Carolyn Y. Ho et al. · Journal of the American College of Cardiology · 2019 · 295 citations · Full text

Cardiomyopathy, Cardiovascular Disease, Physiology +8

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Michael E. Nassif et al. · New England Journal of Medicine · 2024 · 230 citations · Full text